Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV000532679 | SCV000649717 | likely benign | Qualitative or quantitative defects of dysferlin | 2024-11-21 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV004024174 | SCV004861690 | uncertain significance | Inborn genetic diseases | 2023-11-07 | criteria provided, single submitter | clinical testing | The c.5030G>A (p.R1677H) alteration is located in exon 45 (coding exon 45) of the DYSF gene. This alteration results from a G to A substitution at nucleotide position 5030, causing the arginine (R) at amino acid position 1677 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
| Natera, |
RCV001834797 | SCV002082360 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2019-10-28 | no assertion criteria provided | clinical testing |